These results, along with a past report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 support the notion of concentrating on ACKR3 as a novel technique to modulate the opioid system, which could open new therapeutic avenues for opioid-associated Conditions. Disclaimer: The above mentioned is https://joshl051cms4.answerblogs.com/profile